A near-infrared Raman system was developed to collect real-time in vivo human lung spectra. The excitation light and the emission were guided to and from the tissue surface by a reusable fiber catheter passed down the instrument channel of a bronchoscope. Two-stage filtering was used to reduce laser noise, fluorescence, and Raman emissions from the fibers. A second fiber bundle guided the emission to a spectrometer where the fibers, in a round packing geometry, were spread out to form a parabolic arc that improved the signal-tonoise ratio 20-fold, facilitating real-time spectral measurements. Preliminary clinical tests show that clear and reliable Raman spectra can be obtained.
In the 1990s, autofluorescence imaging was developed and applied in vivo to identify early lung cancers [1] . However, the autofluorescence spectra show less specific differences between normal and pathologic sites [2] resulting in a specificity for the diagnostic of ϳ60%. Raman spectroscopy may improve the diagnoses because of its high specificity to individual molecules, as has been shown for a variety of diseases [3] , including malignant tumors found in ex vivo lung tissue [4] . Acquiring an in vivo Raman spectrum is a minimally invasive procedure; however, Raman emissions are generally so weak that real-time in vivo imaging of macroscopic tissue areas is not presently viable. Instead spectra are obtained one at a time by focusing the excitation light into a small spot (a few millimeters in diameter), with the emission collection optics in close proximity to gather as much emission as possible. Thus by itself Raman spectroscopy cannot be used as an efficient method for locating tumors or precancerous lesions, but it could be beneficial if used in conjunction with other imaging modalities. One possibility is for the physician to use autofluorescence imaging to rapidly identify likely sites of concern, then employ Raman spectroscopy for further investigation on these sites. The first stage in testing this idea is to develop a Raman system with a fiber optic catheter that is passed down the instrument channel of a bronchoscope to acquire reliable in vivo Raman spectra.
A schematic of the Raman system we developed is shown in Fig. 1 . The excitation source was a 785 nm 300 mW stabilized diode laser (model BRM-785, B&W Tek). Emissions were analyzed with an f/2.2 spectrograph (model Holospec, Kaiser Optical Systems) in two spectral ranges: low frequencies (LFs) from −200 to 2000 cm −1 and high frequencies (HFs) from 1500 to 3400 cm −1 . The intensity of the dispersed light was measured with a near-infrared optimized, back-illuminated, deep depletion CCD with 400ϫ 1340 pixels, at 20ϫ 20 m per pixel (model Spec-10:400BR/LN, Princeton Instruments). The 1.8 mm diameter 0.75 m long catheter contained ultralow OH fibers: a central 200 m diameter fiber for excitation, surrounded by a total of 27 fibers each measuring 100 m in diameter for the collection of the emitted light. The excitation fiber had a gold coated jacket to prevent photon cross talk. At the proximal end the excitation and emission fibers were separated and coupled to a module containing collimating lenses and filters. The filters consisted of a bandpass filter (SemRock, LL01-785) and two long pass filters: a SemRock LP02-785RU and a 5 mm thick Schott RG 715. The bandpass filter attenuated laser noise, fluorescence, and Raman emissions from the single 200 m fiber that connected the laser to the filter module. The long pass filters blocked all wavelengths Յ790 nm from reaching the spectrometer. Two were required because although the LP02-785RU had a very sharp transmission cutoff close to the laser line, it had significant blue transmission. This was a problem because we wanted to take Raman spectra during autofluorescence imaging to enable the physician to see a wide field of the lung at all times. Thus using the LP02-785RU by itself resulted in the measurement of second order spectra from the blue excitation light of the autofluorescence imaging system; the inclusion of the RG 715 blocked this. Another stage of filtering was incorporated at the distal end of the catheter to reduce fluorescence generated in the fibers [5] . These filters were made by evaporating short and long pass interference coatings onto the excitation and emission fiber tips, respectively. Both of these coatings had transmission cutoffs at Ϸ820 nm, thereby substantially reducing the unwanted fiber emissions, but limiting the Raman shifts available for spectral analysis to frequencies Ͼ500 cm −1 . A second specially designed fiber bundle guided the filtered emission to the spectrometer. This bundle consisted of 54 ultralow OH 100 m diameter fibers packed in a round geometry at the filter module end, but spread out into a parabolic arc at the spectrometer end. The arc was directly coupled to the spectrometer replacing the standard straight line entrance slit. This was done because oblique rays incident on the grating result in curved images of the slit being projected onto the CCD, which lowers the signal-to-noise (S/N) ratio and the spectral resolution of the system [6] . Although the effects of this image curvature can be partially overcome by various combinations of software and hardware CCD pixel binning, the use of the parabolic arc increases the S/N up to 400/ 400 0.5 = 400 0.5 = 20 times that of complete software binning by facilitating full column hardware binning [6] . The exact shape of the parabola was determined by measuring the curvature of a slit image projected onto the CCD and making a correction to account for the ϫ1.13 magnification in the spectrometer.
The system wavelength calibration was done with Ne and Hg standard lamps (Newport Corp.). The spectral resolution was estimated to be Ϸ9 cm −1 for both the LF and HF ranges, which was in agreement with Kaiser's data (10 and 8.5 cm −1 , respectively, assuming a 100 m slit width). The maximum excitation power at the tissue surface was 200 mW, and this did not appear to cause any tissue damage for exposures less than 5 s. However, to prevent the patient from being unduly exposed to high laser powers we incorporated a low power focusing mode. In focusing mode the laser was operated at 10% of its maximum power by fast switching ͑500 Hz͒ it with transistor-transistor logic (TTL) pulses 0.2 ms wide, enabling the physician to see a dim laser spot using the autofluorescence imaging system and thus direct the catheter to the point of interest. A computer with custom designed software was then used to trigger data acquisition at full excitation power, remove the CCD darkcount, apply a five point smoothing, and subtract the autofluorescence background using a seventh order polynomial all in real time [7] . The spectral intensities were corrected for the system response using a standard halogen calibration lamp (RS-10, Gamma Scientific) and an integrating sphere (Newport Corp.), and normalized to the area under each curve. Initial trials (not shown) using the palm skin of a volunteer showed that the shape of the spectra did not significantly change for probe tip to tissue distances between 5 and 25 mm. Although touching the tissue surface with the probe is a configuration most easily reproduced by the physician, the soiling of the tip was a distinct disadvantage for patients where the acquisition of multiple spectra was required. We therefore selected an optimum probe to tissue distance of Ϸ1 cm.
Human subjects for this study were recruited from patients requiring a bronchoscopy procedure as part of their medical care. The study was approved by the BC Cancer Agency Research Ethics Board (certificate H06-00010). Consent was obtained from every patient that participated in the study. The physician identified likely lung sites of concern using both white light and fluorescence imaging. After these sites were identified Raman spectra were obtained from them. Biopsies were then taken of the same sites and sent for histological evaluation. After the pathologist's reports were received the Raman spectra were classified as either normal, mild dysplasia, moderate dysplasia, severe dysplasia, carcinoma in situ (CIS), or as a specific tumor type, e.g., squamous cell carcinoma (SCC). In addition, Raman spectra were obtained from sites that appeared completely normal in the physician's opinion, but no biopsies were obtained. These spectra were classified as normal.
Initial measurements in the LF range (not shown) resulted in spectra dominated by a fluorescence emission, which made it difficult to discern clear Raman peaks in the raw data. Polynomial fitting to remove this fluorescence was only successful between 700 and 1700 cm −1 . Obtaining precise spectra under such high fluorescence background was difficult, and this probably explained the large variability we observed between the spectra from sites with the same pathology. Further investigation showed that nearly all of this fluorescence was coming from the tissue itself excited by the 785 nm laser light and not from the autofluorescence imaging system exciting light or from fluorescence generated in the fiber catheter. A possible explanation for the high autofluorescence from lung tissue is the high levels of hemoglobin close to the tissue surface or some other fluorophore specific to the lung. Despite the high fluorescence the extracted lung Raman spectra still showed a broad similarity to the Raman spectrum of triolein, which is abundant in bronchial mucosa [8] . Figure 2 shows examples of HF in vivo spectra of lung sites with different pathologies. Each spectrum is the average of four spectra taken from the same site. Clear Raman peaks are seen in the raw data. The fluorescence intensities were much less than in the LF range. Polynomial fitting to remove this fluorescence was successful for the whole measured range. We estimate the intensity ratio of extracted Raman peaks to the fluorescence was ϳ6 times greater for the most intense Raman peaks compared to those in the LF range. Thus the experimental uncertainties in processing the data were smaller. The drawback was that there were fewer peaks in the HF range.
The dashed lines shown in Fig. 2 indicate the position of the most prominent peaks. The broad peaks near 1658 cm −1 were probably due to a combination of ͑C v O͒ amide I vibrations [4] and 2 water molecule bending motions [9, 10] . The intense peaks at 2900 cm −1 are assigned to a combination of CH 2 antisymmetric ͑2880 cm −1 ͒ and CH 3 symmetric ͑2935 cm −1 ͒ stretching modes of phospholipids and proteins. The broad peaks near 3300 cm −1 were most likely due to overlapping 1 and 3 symmetric and antisymmetric OH stretching motions of water [9] . These water peaks showed considerable variability. This may be because detected signals at this spectral end were fairly weak so the uncertainties were high. However, it should be mentioned that hydrogen bonding of water is particularly sensitive to its surroundings leading to peak broadening and shifting (see [9, 10] and references therein). Between 1658 and 2885 cm −1 there are a number of low intensity peaks that show considerable variability between the spectra. Generally this spectral region is not noted for any significant Raman peaks. However a comprehensive review by Movasaghi et al. [10] lists a number of possibilities that mainly involve carbon, nitrogen, and oxygen modes, which are in approximate agreement with many of the peaks we observe.
The fact that our system could obtain clear HF spectra with a short integration time was very encouraging. Nijssen et al. [5] have shown that the phospholipid peaks near 2900 cm −1 can be used to discriminate between diseased and normal skin tissue with high accuracy. The SCC spectrum we obtained was dramatically different from the other three spectra, and the moderate dysplasia spectrum was very close to the normal spectrum. The CIS spectrum had features similar to the SCC spectrum, but also features similar to the moderate dysplasia spectrum. Overall, the spectra we obtained from the two malignant lesions (SCC and CIS) could be easily differentiated from the spectra we obtained from the benign lesion (moderate dysplasia) and normal tissue. However, at this stage we cannot rule out the possibility that the differences we observed are due to tissue heterogeneity and/or interpatient variability. A large clinical study is underway to test the utility of the spectra for improving lung cancer detection.
In conclusion, an aberration corrected rapid Raman system and a special endoscopic Raman probe have been designed, constructed, and evaluated. We successfully acquired, for the first time to our knowledge, in vivo lung Raman spectra. The spectral measurement can be performed in real-time with 1 -2 s integration times. We found that strong autofluorescence of the lung rendered the extraction of Raman signals in the LF range unreliable. However, clear in vivo lung Raman spectra could be obtained using the HF range. These findings indicate that there is a real possibility that in vivo lung tissue can be characterized at the molecular level using Raman spectroscopy and that a way of improving the early detection of lung cancers can be developed. 
